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This document shall serve as a  list of  recommendations of  the  Polish Dental Association and National Pro-
gramme to Protect Antibiotics Working Group for antibiotic administration in dentistry.
There are two indications for antibiotic administration in dentistry: antibiotic prophylaxis (against surgical site 
infections or distant infections) and antibiotic treatment (of an already existing oral infection). It is very important 
to emphasize that maintaining proper oral hygiene and using aseptic and antiseptic techniques are of paramount 
importance for prevention of oral infections, whereas causative dental treatment constitutes an essential step in their 
treatment. Antibiotic administration is no substitute for the foregoing.
The following recommendations have been formulated on the basis of  the available scientific data regarding 
specific areas of  dentistry. They do not, however, override in any way whatsoever the  individual responsibility 
of  dentists to make appropriate and accurate decisions in consideration of  each patient’s health condition and 
in consultation with that patient or the patient’s caregiver where appropriate or necessary. It is also the dentist’s 
responsibility to verify the rules and regulations applicable to medications at the time of prescription.
The present recommendations have been mostly formulated on the basis of the consensus of opinion of the ex-
perts and/or of the results of retrospective studies (level of evidence C) or data derived from single randomized clini-
cal trials (level B) as data derived from multiple randomized clinical trials or meta-analyses (level A) are available 
only for very few indications for antibiotic administration in dentistry.
Members of the Working Group preparing these recommendations stress that antibiotics are significantly mis-
used and overused in dentistry, despite the fact that an alarming increase in bacterial resistance to antibiotics is ob-
served, and it constitutes one of the major problems of contemporary medicine. Consequently, whenever antibiotic 
administration is considered, a dentist should weigh the potential benefits and risks resulting from this decision, 
since in dentistry in most cases individual (for a patient) and collective (for a society) risks of antibiotic administra-
tion outweigh its possible benefits (prevention or treatment of infection).
Journal of Stomatology * http://www.jstoma.com458
Tomasz Kaczmarzyk, Karolina Babiuch, Elżbieta Bołtacz-Rzepkowska, et al.
RECOMMENDATIONS FOR ANTIBIOTIC 
PROPHYLAXIS AGAINST SURGICAL SITE 
INFECTIONS
GENERAL RECOMMENDATIONS FOR ANTIBIOTIC PROPHYLAXIS 
AGAINST SURGICAL SITE INFECTIONS IN ORAL AND 
MAXILLOFACIAL SURGERY
•	 Maintaining proper oral hygiene and using aseptic and 
antiseptic techniques are of paramount importance 
for prevention of oral and maxillofacial infections.
•	 Routine administration of  antibiotic prophylaxis in 
immunocompetent patients is not recommended; 
the decision of administration of antibiotic prophylaxis 
should be very prudent.
•	 Antibiotic prophylaxis is recommended in immuno-
compromised1 patients, in consultation with the at-
tending physician.
•	 Antibiotic prophylaxis should be administered 30-60 
minutes before commencement of surgery.
•	 For prophylaxis, it is recommended to administer only 
one dose of an antibiotic (one-shot prophylaxis) and 
no further doses after completion of surgery should be 
administered, with the exceptions presented in certain 
detailed recommendations (ultra-short, short-term 
and long-term prophylaxis). 
•	 Unless otherwise specified in the  detailed recom-
mendation, for antibiotic prophylaxis in dentistry 
amoxi cillin without clavulanic acid in a  single dose 
of 2000 mg is recommended; patients allergic to pen-
icillins should be given cefazolin2 in a  single dose 
of 1000 mg or clindamycin in a single dose of 600 mg.
•	 Unless otherwise specified in the  detailed recom-
mendation, for antibiotic prophylaxis in pediat-
ric patients amoxicillin without clavulanic acid in 
a single dose of 50 mg/kg is recommended; patients 
allergic to penicillins should be given cefazolin2 in 
a single dose of 50 mg/kg or clindamycin in a single 
dose of 20 mg/kg.
1 An immunocompromised patient is usually a  patient: (1) affected 
with hematological or congenital/acquired immunodeficiency (e.g. 
hypogammaglobulinemia, lymphoma, leukemia, Chediak-Higashi 
syndrome, DiGeorge syndrome, HIV+ with CD4 count < 100/mm3 
and neutrophil count < 500/mm3, (2) on immunosuppressive, cyto-
toxic or steroid therapy (e.g. transplant or cancer patients, systemic 
connective tissue disease), (3) affected with chronic and unregulated 
metabolic disease (e.g. poor glycemic control diabetes, hepatic cirrho-
sis, renal insufficiency, malnutrition).
2 Cephalosporins should not be used in patients with a history of ana-
phylaxis, angio-edema, or urticaria after intake of penicillins.
SPECIFIC RECOMMENDATION FOR ANTIBIOTIC PROPHYLAXIS 
AGAINST SURGICAL SITE INFECTIONS IN THIRD MOLAR SURGERY
•	 Routine administration of antibiotic prophylaxis in 
third molar surgery in immunocompetent patients 
is not recommended; antibiotic prophylaxis should 
be considered in immunocompromised patients in 
consultation with the attending physician or when-
ever it is necessary to perform surgery in the course 
of acute pericoronitis.
SPECIFIC RECOMMENDATION FOR ANTIBIOTIC PROPHYLAXIS 
AGAINST SURGICAL SITE INFECTIONS IN IMPLANT SURGERY
•	 Routine administration of antibiotic prophylaxis in 
implant surgery in immunocompetent patients is 
not recommended; antibiotic prophylaxis should 
be considered in immunocompromised patients in 
consultation with the attending physician. 
•	 It is recommended to consider administration of anti-
biotic prophylaxis in implant procedures involving 
bone grafting.
SPECIFIC RECOMMENDATION FOR ANTIBIOTIC PROPHYLAXIS 
AGAINST SURGICAL SITE INFECTIONS IN BONE GRAFTING SURGERY
•	 It is recommended to consider administration of anti-
biotic prophylaxis in bone grafting surgery.
SPECIFIC RECOMMENDATION FOR ANTIBIOTIC PROPHYLAXIS 
AGAINST SURGICAL SITE INFECTIONS IN DENTO-ALVEOLAR SURGERY
•	 Routine administration of  antibiotic prophylaxis 
in dento-alveolar surgery (e.g. surgical extraction, 
cystectomy or intraosseous bone tumor removal) in 
immunocompetent patients is not recommended; 
antibiotic prophylaxis should be considered in im-
munocompromised patients, in consultation with 
the attending physician. 
•	 It is recommended to administer one dose of antibi-
otic prophylaxis in case of dento-alveolar surgery in-
volving exposure of antral or nasal mucosa as well as 
involving removal of extensive bone cysts and tumors.
SPECIFIC RECOMMENDATION FOR ANTIBIOTIC PROPHYLAXIS 
AGAINST SURGICAL SITE INFECTIONS IN ENDODONTIC SURGERY
•	 Routine administration of antibiotic prophylaxis in 
endodontic surgery in immunocompetent patients 
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is not recommended; antibiotic prophylaxis should 
be considered in immunocompromised patients, in 
consultation with the attending physician. 
SPECIFIC RECOMMENDATION FOR ANTIBIOTIC PROPHYLAXIS 
AGAINST SURGICAL SITE INFECTIONS IN PERIODONTAL SURGERY
•	 Routine administration of antibiotic prophylaxis in 
periodontal surgery in immunocompetent patients 
is not recommended; antibiotic prophylaxis should 
be considered in immunocompromised patients, in 
consultation with the attending physician. 
SPECIFIC RECOMMENDATION FOR ANTIBIOTIC PROPHYLAXIS 
AGAINST SURGICAL SITE INFECTIONS IN ORTHOGNATHIC SURGERY
•	 It is recommended to administer antibiotic prophylaxis 
in orthognathic procedures with intraoral surgical ap-
proach or involving exposure of antral or nasal mucosa. 
•	 In this indication IV ampicillin/sulbactam adminis-
tration 30-60 minutes before commencement of sur-
gery is recommended: in adults in a dose of 1500 mg 
and in children in a dose of 50 mg/kg, and:
■ during prolonged (> 4 h) procedures another dose 
of antibiotic should be administered;
■ in extensive procedures involving high blood loss 
(> 1000 ml) it is recommended to continue admi-
nistration of  antibiotic prophylaxis every 6-8 h 
during the first 24 h after the first dose (ultra-short 
prophylaxis).
•	 Patients allergic to penicillin should be given clin-
damycin in a dose of 600 mg (adults) or 20 mg/kg 
(children), according to the abovementioned design.
SPECIFIC RECOMMENDATION FOR ANTIBIOTIC PROPHYLAXIS 
AGAINST SURGICAL SITE INFECTIONS IN MAXILLOFACIAL SURGERY
•	 Routine administration of antibiotic prophylaxis in 
soft tissue procedures involving extraoral surgical 
approach (e.g. parotidectomy) or in neck dissections 
without opening of airways is not recommended.
•	 Antibiotic prophylaxis is recommended in maxillofa-
cial procedures involving: bone resection, free or pe-
diculated flaps, neck dissections with opening of air-
ways and bone grafting.
•	 In these indications IV ampicillin/sulbactam admini- 
stration 30-60 minutes before commencement of sur-
gery is recommended: in adults in a dose of 1500 mg 
and in children in a dose of 50 mg/kg, and:
■ during prolonged (> 4 h) procedures another 
dose of antibiotic should be administered;
■ in extensive procedures involving high blood loss 
(> 1000 ml) it is recommended to continue ad-
ministration of antibiotic prophylaxis every 6-8 h 
during the first 24 h after the first dose (ultra-short 
prophylaxis).
•	 Patients allergic to penicillin should be given clin-
damycin in a dose of 600 mg (adults) or 20 mg/kg 
(children), according to the abovementioned design.
SPECIFIC RECOMMENDATION FOR ANTIBIOTIC PROPHYLAXIS 
AGAINST SURGICAL SITE INFECTIONS IN PATIENTS  
ON ANTIRESORPTIVE/ANTIANGIOGENIC THERAPY  
OR WITH A HISTORY OF MAXILLOFACIAL RADIOTHERAPY
•	 It is recommended to administer antibiotic prophyla-
xis in patients taking bisphosphonates, denosumab or 
bevacizumab before any surgical procedure involving 
bone surgery (e.g. exodontia, dento-alveolar surgery, 
endodontic or periodontal surgery); antibiotic therapy 
should be initiated one day before surgery and contin-
ued until the 3rd postoperative day (short-term prophy-
laxis), with the exception of cases of  concurrent risk 
factors for medication-related osteonecrosis of the jaw 
(therapy with zoledronic acid, intravenous route 
of bis phosphonate administration, therapy > 3 years, 
previous episode of  osteonecrosis of  the  jaw) where 
antibiotic prophylaxis should be continued up until 
the 14th postoperative day (long-term prophylaxis).
•	 It is recommended to administer antibiotic prophy-
laxis in patients with a  history of  maxillofacial ra-
diotherapy before any surgical procedure involving 
bone surgery (e.g. exodontia, dento-alveolar surgery, 
endodontic or periodontal surgery); antibiotic ther-
apy should be initiated one day before surgery and 
continued until the 3rd postoperative day (short-term 
prophylaxis).
•	 In these indications amoxicillin/clavulanic acid is 
recommended: in adults – 1000 mg (875 mg + 125 mg) 
BID and in children – (45 mg + 6.4 mg)/kg/day in 
2 divided doses; patients allergic to penicillins should 
be medicated with clindamycin: in adults 300 mg 
TID and in children – 8-16 mg/kg/day in 3-4 divided 
doses.
SPECIFIC RECOMMENDATION FOR ANTIBIOTIC PROPHYLAXIS 
AGAINST INFECTIONS OF WOUNDS OF FACIAL SKIN OR ORAL MUCOSA
•	 Antibiotic prophylaxis against infections of  minor, 
fresh3 (< 12 h) wounds in immunocompetent patients 
is not recommended.
•	 Antibiotic prophylaxis is recommended in the case 
of wounds following:
■ blunt injury, 
■ gunshot, bite or avulsion injury,
■ injury inflicted with dirty object,
■ dirty wounds, > 12 h old with no previous dress-
ing,
3 Due to the very good blood supply of head and neck tissues, wounds 
in these areas usually maintain their sterility for longer periods than in 
other anatomical sites.
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■ patients with a previous episode of IE,
■ 30-60 minutes before commencement of a dental 
procedure requiring manipulation of  the  gingi-
val or periapical region of the teeth or perforation 
of oral mucosa should receive:
- PO amoxicillin (without clavulanic acid) or 
IV ampicillin (without sulbactam): adults – 
2000 mg, children – 50 mg/kg; 
■ in patients allergic to penicillins one of  the  fol-
lowing should be administered 30-60 minutes 
before the procedure:
- PO or IV clindamycin: adults – 600 mg, chil-
dren – 20 mg/kg,
- IV cefalexin5: adults – 2000 mg, children – 
50 mg/kg,
- IV cefazolin5: adults – 1000 mg, children – 
50 mg/kg,
- IV ceftriaxone5: adults – 1000 mg, children – 
50 mg/kg.
•	 Antibiotic prophylaxis is not recommended in any 
other congenital or acquired heart disease or in pa-
tients with a  history of  myocardial or cerebral in-
farction, bypass surgery or patients with a implanted 
pacemaker.
•	 Antibiotic prophylaxis is not recommended for local 
anesthetic injections in non-infected tissues, treat-
ment of dental caries, removal of sutures, placement 
or adjustment of removable prosthodontic or ortho-
dontic appliances or braces and following the shed-
ding of deciduous teeth or trauma to the lips or oral 
mucosa.
RECOMMENDATION FOR ANTIBIOTIC PROPHYLAXIS AGAINST 
PERIPROSTHETIC JOINT INFECTIONS FOLLOWING DENTAL 
PROCEDURES
•	 Antibiotic prophylaxis in patients with artificial joint 
prostheses before any dental procedure is not recom-
mended.
RECOMMENDATION FOR ANTIBIOTIC THERAPY 
OF ODONTOGENIC INFECTIONS
•	 Antibiotic therapy is not recommended for treatment 
of  limited, non-spreading odontogenic infections 
which are not associated with the  impaired general 
state in immunocompetent patients.
•	 Local treatment consisting of pus drainage and ex-
traction or endodontic therapy of a causative tooth 
is fundamental for treatment of odontogenic infec-
tions.
•	 Antibiotic therapy of odontogenic infections is indi-
cated in immunocompromised patients (in consul-
5 Cephalosporins should not be used in patients with a history of ana-
phylaxis, angio-edema, or urticaria after intake of penicillins.
■ injuries in immunocompromised patients, in con-
sultation with the attending physician.
•	 In these indications it is recommended to adminis-
ter a  single dose of either IV ampicillin/sulbactam: 
adults – 1500 mg, children – 50 mg/kg or PO amoxi-
cillin/clavulanic acid: adults – 2000 mg, children – 
(45 mg + 6.4 mg)/kg.
SPECIFIC RECOMMENDATION FOR ANTIBIOTIC PROPHYLAXIS 
AGAINST INFECTIONS OF BONE FRACTURES
•	 Antibiotic prophylaxis against infection of closed frac-
tures (e.g. fractures of condyle or mandible ramus) in 
immunocompetent patient is not recommended, in-
sofar as conservative or surgical treatment involving 
the extraoral approach is applied.
•	 Antibiotic prophylaxis is recommended in the case of:
■ open fractures (e.g. mandible body fracture),
■ fractures with delayed treatment,
■ pathologic fractures,
■ surgically treated fractures involving the  intra-
oral approach,
■ comminuted fractures,
■ fractures involving nasal or paranasal sinuses mu-
cosa exposure,
■ fractures in immunocompromised patients, in con-
sultation with the attending physician.
•	 In these indications clindamycin in a  single dose of 
600 mg in adults or 20 mg/kg in children is recom-
mended.
RECOMMENDATIONS FOR ANTIBIOTIC 
PROPHYLAXIS AGAINST DISTANT INFECTIONS
RECOMMENDATION FOR ANTIBIOTIC PROPHYLAXIS AGAINST 
INFECTIVE ENDOCARDITIS (IE) FOLLOWING DENTAL PROCEDURES4
•	 Strict oral hygiene and frequent dental follow-up in 
IE high-risk patients are decidedly recommended.
•	 It is recommended that patients with cardiac condi-
tions at the highest risk of IE, including:
■ patients with any prosthetic valve, including a trans-
catheter valve, or those in whom any prosthetic ma-
terial was used for cardiac valve repair;
■ patients with congenital heart disease (CHD):
- any type of cyanotic CHD,
- any type of CHD repaired with a prosthetic 
material, whether placed surgically or by per-
cutaneous techniques, up to 6 months after 
the procedure or lifelong if residual shunt or 
valvular regurgitation remains;
4 This recommendation conforms to the 2015 Guidelines of European 
Society of  Cardiology for the  management of  infective endocarditis 
(Habib, et al. 2015 ESC Guidelines for the  management of  infective 
endocarditis. Eur Heart J 2015; 36: 3075-3123).
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tation with the  attending physician where possible); 
however, in immunocompetent patients antibiotic 
therapy is only complementary to the local treatment 
and should be administered solely in patients with 
an impaired general state (high fever, malaise, vertigo, 
dehydration, tachycardia) or in cases of inflammation 
involving extraoral anatomical spaces with a tendency 
to spread.
•	 Only in exceptional circumstances, when there is 
no possibility of immediate causative treatment (e.g. 
high trismus, lack of  efficacy of  local anaesthesia), 
may administration of  antibiotic to reduce inflam-
mation be considered; however, causative treatment 
should be implemented without any further delay. 
•	 In the case of empirical antibiotic therapy (without 
results of laboratory testing for bacterial sensitivity) 
amoxicillin without clavulanic acid should be ad-
ministered as the first-line therapy (Table 1).
•	 Clindamycin is recommended only in patients al-
lergic to penicillins, and it should be administered 
every 6-8 h (but not every 12 h), and a single dose 
should not exceed 300 mg (Table 1).
•	 It is recommended that every patient treated with an-
tibiotic should be followed up on a regular basis and 
the  first follow-up should take place not later than 
48-72 h after commencement of antibiotic therapy.
•	 Antibiotic therapy should be continued until sig-
nificant improvement in the  patient’s general state 
(decrease of body temperature, wellbeing), in which 
case antibiotic therapy should be ceased. 
•	 It is recommended that if there is no improvement in 
the patient’s general state after 72 h of antibiotic ther-
apy a  second-line antibiotic should be considered, 
and the efficacy of drainage should be re-evaluated.
•	 The list of recommended antibiotics in empirical ther-
apy is annexed to this recommendation (Table 1).
TABLE 1. Antibiotics recommended for treatment of odontogenic infections
Adults Children
First-line therapy
Oral administration Amoxicillin 500 mg TID or 750-1000 mg BID; 
TID scheme usually shows greater 
effectiveness 
children up to 40 kg: 20-40 mg/kg/day  
in 3 divided doses
children over 40 kg: as in adults
Parenteral administration Ampicillin 500 mg QID children up to 20 kg: 12.5 mg/kg QID
children over 20 kg: as in adults
Second-line therapy*
Oral or parenteral administration Amoxicillin/ 
Clavulanic acid
875 mg + 125 mg BID children up to 40 kg: (45 mg + 6.4 mg)/kg/day  
in 2 divided doses
children over 40 kg: as in adults
Clindamycin 150 mg QID or 300 mg TID† children up to 14 years of age: 8-16 mg/kg/day  
in 3-4 divided doses
children over 14 years of age: as in adults
Parenteral administration Ampicillin/Sulbactam 500 mg + 250 mg TID or QID (100 mg + 50 mg)/kg/day in 3-4 divided doses
Alternative therapy**
Oral administration Cefuroxime axetil 500 mg BID children over 3 months of age: 20 mg/kg/day  
in 2 divided doses
children over 12 years of age: 250 mg BID
Spiramycin 3,000,000 IU BID 150,000 IU/kg/day in 2-3 divided doses
Clarithromycin 250 mg BID body mass up to 8 kg: 7.5 mg/kg BID
body mass 8-11 kg: 62.5 mg BID
body mass 12-19 kg: 125 mg BID
body mass 20-30 kg: 187.5 mg BID
body mass over 30 kg: as in adults
Azithromycin 500 mg QD 10 mg/kg/day QD
Oral or parenteral administration Metronidazole (usually 
co-administered with 
amoxicillin or penicillin V)
500 mg TID up to 12 years of age: 7.5 mg/kg TID
over 12 years of age: as in adults
*Recommended whenever first-line therapy is difficult, improper or contraindicated or when there is no response to first-line therapy after 48-72h. 
**Recommended whenever contraindications for first- and second-line therapy occur. 
†Single oral dose of clindamycin should not exceed 300 mg and intervals between doses should not be longer than 8 h; single oral dose of clindamycin over 450 mg should be 
reserved for parenteral administration for treatment of severe and life-life-threatening infections.
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RECOMMENDATION FOR ANTIBIOTIC THERAPY 
IN PERIODONTITIS AND PERIIMPLANTITIS
•	 Routine administration of  antibiotics for the  treat-
ment of  periodontitis and peri-implantitis in immu-
nocompetent patients is not recommended; mecha nical 
therapy involving removal of  supra- and sub gingival 
deposits of calculus and dental plaque by means of scal-
ing and root planing (SRP) plays a fundamental role in 
periodontal therapy.
•	 Systemic antibiotic administration is recommended 
in patients with acute symptoms of the periodontal 
disease such as multiple periodontal abscesses and 
necrotizing periodontal diseases with systemic in-
volvement (high fever, malaise, vertigo, dehydration, 
tachycardia).
•	 Administration of antibiotic therapy should also be 
considered in the case of A. actinomycetemcomitans 
and/or P. gingivalis infection in the  course of  re-
fractory periodontitis in stage IV of the disease (ac-
cording to the 2017 classification of periodontal and 
peri-implant diseases)[11].
•	 It is recommended to consider systemic antibiotic 
administration for treatment of  periodontitis and 
peri-implantitis in immunocompromised patients 
(in consultation with the attending physician).
•	 Administration of systemic antimicrobials should be 
preceded by culture and sensitivity microbiological 
testing whenever possible.
•	 In the  case of  empirical antibiotic therapy of  multi-
ple periodontal abscesses amoxicillin/clavulanic acid 
is recommended: in adults and children over 40 kg 
– 1000 mg (875 mg + 125 mg) BID for 5 days, and 
in children up to 40 kg – (45 mg + 6.4 mg)/kg/day 
in two divided doses for 5 days; in patients allergic to 
penicillins azithromycin is recommended: in adults – 
500 mg QD for 3 days, and in children – 10 mg/kg QD 
for 3 days; in this indication administration of antibi-
otic should be simultaneous with mechani cal therapy.
•	 In the case of empirical antibiotic therapy of necro-
tizing periodontal diseases administration of  met-
ronidazole is recommended: in adults and children 
over the age of 12 – 250 mg TID for 7 days, and in 
children up to 12 years of age – 7.5 mg/kg TID for 
7 days; in this indication administration of antibiotic 
should be simultaneous with mechanical therapy.
•	 In the  case of  empirical antibiotic therapy of  stage 
IV of  periodontitis, co-administration of  amoxicillin 
(without clavulanic acid) and metronidazole for 7 days 
is recommended according to the following scheme:
■ in adults and children over 40 kg amoxicillin 
should be administered in a dose of 500 mg TID, 
and in children up to 40 kg – 40 mg/kg/day in 
3 divided doses, 
■ in adults and children over the  age of  12 met-
ronidazole should be administered in a  dose of 
250 mg TID, and in children up to 12 years of age 
– 7.5 mg/kg TID,
■ in patients allergic to penicillins, administration 
of  metronidazole alone according to the  above 
scheme is recommended, 
■ it is recommended to commence antibiotic therapy 
on the day of completion of mechanical therapy. 
RECOMMENDATIONS FOR THE USE 
OF ANTIBIOTICS IN ENDODONTICS6
RECOMMENDATION FOR SYSTEMIC ANTIBIOTIC PROPHYLAXIS  
IN ENDODONTICS
•	 Routine administration of antibiotic prophylaxis be-
fore root canal treatment in immunocompetent pa-
tients is not recommended. 
•	 Antibiotic prophylaxis before root canal treatment is 
recommended only in:
■ immunocompromised patients, after considering 
the  state and control of  the  disease, risk of  infec-
tion-related complications and risk of adverse drug 
reactions,
■ patients with cardiac conditions at the  highest 
risk of IE,
■ patients with previous radiotherapy of the maxil-
lofacial region.
•	 In the  event of  a  decision of  antibiotic prophylaxis 
administration before root canal treatment,  antibi-
otic selection and dosing should follow “Recommen-
dation for antibiotic prophylaxis against infective en-
docarditis (IE) following dental procedures”.
RECOMMENDATION FOR SYSTEMIC ANTIBIOTIC THERAPY  
IN ENDODONTICS
•	 Local treatment plays a  fundamental role in therapy 
of  endodontic infections, whereas adjunctive systemic 
antibiotic treatment is indicated only in the following 
conditions:
■ acute periapical abscess in immunocompromised 
patients, 
■ acute periapical abscess with systemic involve-
ment (high fever, malaise, vertigo, dehydration, 
tachycardia) or advanced local signs (lymphade-
nopathy, extensive swelling, severe trismus), irre-
spective of patient’s immunological status,
■ progressive infections (rapid onset of severe in-
fection in less than 24 h, cellulitis/phlegmon, 
acute osteomyelitis). 
6 Recommendations of Polish Dental Association for the use of antibio-
tics in endodontics are in line with the position statement of the Euro-
pean Society of Endodontology from the year 2017 (Segura-Egea, et al. 
European Society of Endodontology position statement: the use of anti-
biotics in endodontics. Int Endod J 2017; 51: 20-25).
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for the  first week after the  replantation procedure; 
due to the risk of discoloration of permanent teeth, in 
non-penicillin-allergic children up to 12 years of age 
phenoxymethylpenicillin (penicillin V) or amoxicil-
lin (without clavulanic acid) should be considered in 
an appropriate dose for the age and weight; in the case 
of replantation of an immature tooth, topical applica-
tion of antibiotic (minocycline or doxycycline, 1 mg 
per 20 ml of saline for 5 min) on the root surface be-
fore replantation should be considered.
•	 The decision about the systemic use of an antibiotic 
may be dictated by associated injuries and the  pa-
tient’s medical status. 
References 
1. Abel SN, Croser D, Fischman SL, et al. Principles of oral health 
management for the  HIV/AIDS patient. 2000 edition. Dental 
Alliance for AIDS/HIV Care. Philadelphia: http://www.aids-ed.
org/pdf/curricula/Princ_Oral_Health_HIV.pdf
2. Abu-Ta’a M. Adjunctive systemic antimicrobial therapy vs asep-
sis in conjunction with guided tissue regeneration: a randomized, 
controlled clinical trial. J Contemp Dent Pract 2016; 17: 3-6. 
3. Albrektsson T, Dahlin C, Jemt T, et al. Is marginal bone loss 
around oral implants the result of a provoked foreign body reac-
tion? Clin Implant Dent Rel Res 2014; 16: 155-165.
4. Aminoshariae A, Kulild JC. Evidence-based recommendations 
for antibiotic usage to treat endodontic infections and pain. A sys-
tematic review of randomized controlled trials. J Am Dent Assoc 
2016; 17: 3-6. 
5. Andersson L, Andreasen JO, Day P, et al. International Associ-
ation of  Dental Traumatology guidelines for the  management 
of traumatic dental injuries: 2. Avulsion of permanent teeth. Dent 
Traumatol 2012; 28: 88-96. 
6. Arteagoitia I, Ramos E, Santamaria G, et al. Amoxicillin/clavu-
lanic acid 2000/125 mg to prevent complications due to infection 
following completely bone-impacted lower third molar removal: 
a clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol 2015; 
119: 8-16.
7. Asi KS, Gill AS, Mahajan S. Postoperative bacteremia in perio-
dontal flap surgery, with and without prophylactic antibiotic ad-
ministration: a comparative study. J Indian Soc Periodontol 2010; 
14: 18-22. 
8. Assem NZ, Alvez MLF, Lopes AB, et al. Antibiotic therapy as 
an adjunct to scaling and root planing in smokers: a  systematic 
review and meta-analysis. Braz Oral Res 2017; 31: e67.
9. Bamias A, Kastritis E, Bamia C, et al. Osteonecrosis of the jaw in 
cancer after treatment with bisphosphonates: incidence and risk 
factors. J Clin Oncol 2005; 23: 8580-8587.
10. Bortoluzzi MC, Capella DL, Barbieri T, et al. A single dose of amo-
xicillin and dexamethasone for prevention of postoperative compli-
cations in third molar surgery: a randomized, double-blind, place-
bo controlled clinical trial. J Clin Med Res 2013; 5: 26-33.
11. Caton JG, Armitage G, Berglundh T, et al. A  new classification 
scheme for periodontal and peri-implant diseases and condi-
tions – introduction and key changes from the 1999 classification. 
J Periodontol 2018; 89 Suppl 1: S1-S8.
12. Cherry WR, Lee JY, Shugars DA, et al. Antibiotic use for treating 
dental infections in children. JADA 2012; 143: 31-38.
13. Chrcanovic BR, Albrektsson T, Wennerberg A. Prophylactic anti-
biotic regimen and dental implant failure: a meta-analysis. J Oral 
Rehabil 2014; 41: 941-956.
14. Critser G. Generation Rx: How prescription drugs are alerting 
American lives, minds and bodies. Houghton Mifflin, New York 
2005; 106-110.
•	 Adjunctive systemic antibiotic treatment is not rec-
ommended in the following conditions:
■ symptomatic irreversible pulpitis (pain with no 
other signs and symptoms of infection), 
■ pulp necrosis,
■ symptomatic periapical periodontitis (sponta-
neous pain, pain to percussion and biting, wid-
ening of periodontal ligament space), 
■ chronic periapical periodontitis/chronic periapi-
cal abscess (periapical radiolucency, sinus tract), 
■ acute periapical abscess without systemic in-
volvement (normal body temperature, patient 
well-being) and with mild localized symptoms 
(e.g. localized swelling).
•	 In the event of a decision of antibiotic therapy of end-
odontic infection, antibiotic selection and dosing 
should follow “Recommendations for antibiotic ther-
apy of odontogenic infections”.
RECOMMENDATION FOR LOCAL ANTIBIOTIC APPLICATION IN 
ENDODONTICS
•	 Antibiotics are not recommended in pulp capping 
procedures or for root canal disinfection.
•	 Due to the  fact that the  antibiotic mixture com-
posed of  ciprofloxacin, metronidazole and mino-
cycline known as triple antibiotic paste (TAP) may 
cause dentine discoloration and that there is a  lack 
of strong evidence to support the use of antibiotics in 
regenerative endodontic procedures, the use of cal-
cium hydroxide for pulp revascularization is recom-
mended.
RECOMMENDATION FOR THE USE 
OF ANTIBIOTICS IN DENTAL TRAUMA7
•	 Routine administration of antibiotics is not recom-
mended in the following conditions:
■ crown fracture, root fracture, concussion, sub-
luxation and partial luxation of  a  permanent 
tooth,
■ trauma to primary dentition.
•	 Avulsion of a permanent tooth is an indication for sys-
temic antibiotic administration, in which case tetra-
cycline is recommended in the dose of 25 mg/kg/day 
7 Recommendations of  the  Polish Dental Association for the  use 
of  antibiotics in dental traumatology are in line with guidelines 
of  the  International Association of  Dental Traumatology (Diangelis, 
et al. International Association of Dental Traumatology guidelines for 
the  management of  traumatic dental injuries: 1. Fractures and luxa-
tions of permanent teeth. Dent Traumatol 2012; 28: 2-12; Andersson, 
et al. International Association of Dental Traumatology guidelines for 
the management of traumatic dental injuries: 2. Avulsion of permanent 
teeth. Dent Traumatol 2012; 28: 88-96; Malmgren, et al. International 
Association of  Dental Traumatology guidelines for the  management 
of  traumatic dental injuries: Injuries in the  primary dentition. Dent 
Traumatol 2012; 28: 174-82).
Journal of Stomatology * http://www.jstoma.com464
Tomasz Kaczmarzyk, Karolina Babiuch, Elżbieta Bołtacz-Rzepkowska, et al.
15. Dakic A, Boillot A, Colliot C, et al. Detection of Porphyromonas 
gingivalis and Aggregatibacter actinomycetemcomitans after sys-
temic administration of amoxicillin plus metronidazole as an ad-
junct to non-surgical periodontal therapy: a systematic review and 
meta-analysis. Front Microbiol 2016; 19: 1277.
16. Danda AK, Ravi P. Effectiveness of postoperative antibiotics in or-
thognathic surgery: a metaanalysis. J Oral Maxillofac Surg 2011; 
69: 2650-2656. 
17. Del Fabrro M, Corbella S, Sequeira-Byron P, et al. Endodontic 
procedures for retreatment of periapical lesions. Cochrane Data-
base Syst Rev 2016; 19: CD005511. 
18. Diangelis AJ, Andreasen JO, Ebeleseder KA, et al. International 
Association of  Dental Traumatology guidelines for the  man-
agement of  traumatic dental injuries: 1. Fractures and luxations 
of permanent teeth. Dent Traumatol 2012; 28: 2-12. 
19. Esposito M, Grusovin MG, Worthington HV. Interventions for 
replacing missing teeth: antibiotics at dental placement to prevent 
complications (review). Cochrane Database Syst Rev 2013; 31: 
CD004152.
20. European Society of  Cardiology. 2015 ESC Guidelines for 
the management of  infective endocarditis. Eur Heart J 2015; 36: 
3075-3123.
21. Flynn TR. What are the  antibiotics of  choice for odontogenic 
infections, and how long should the treatment course last? Oral 
Maxillofac Surg Clin North Am 2011; 23: 519.
22. Glenny AM, Oliver R, Roberts GJ, et al. Antibiotics for the pro-
phylaxis of bacterial endocarditis in dentistry. Cochrane Database 
Syst Rev 2013; 10: CD003813.
23. Gluck B. The  advisability of  immediate extraction in cases 
of swelling. Dental Items Interest 1939; 61: 225. 
24. Guerrero JS. Use of prophylactic antibiotic therapy in oral surgical 
procedures: a critical review. J Calif Dent Assoc 2008; 36: 943-950.
25. Habib G, Lancellotti P, Iung B. 2015 ESC Guidelines on the man-
agement of  infective endocarditis: a big step forward for an old 
disease. Heart 2016; 102: 992-994. 
26. Hallström H, Persson GR, Lindgren S, Renvert S. Open flap de-
bridement of peri-implantitis with or without adjunctive systemic 
antibiotics – a randomized clinical trial. J Clin Periodontol 2017; 
44: 1285-1293.
27. Heim N, Faron A, Wiedemeyer V, et al. Microbiology and anti-
biotic sensitivity of head and neck space infections of odontogen-
ic origin. Differences in inpatient and outpatient management. 
J Craniomaxillofac Surg 2017; 45: 1731-1735.
28. Hryniewicz W, Kulig J, Ozorowski T, et al. Stosowanie anty-
biotyków w profilaktyce okołooperacyjnej. Narodowy Instytut 
Leków, Warszawa 2011.
29. Horliana AC, Chambrone L, Foz AM, et al. Dissemination 
of  perio dontal pathogens in the  bloodstream after periodontal 
procedures: a systematic review. PLoS One 2014; 9: e98271.
30. Hought RT, Fitzgerald BE, Latta JE, Zallen RD. Ludwig’s angina: 
report of two cases and review of the literature from 1945 to Janu-
ary 1979. J Oral Surg 1980; 38: 849.
31. Hullah E. Antimicrobials – antibiotics. Wray D (ed.). In: Essential 
dental therapeutics. Wiley Blackwell, Oxford 2018: 31-40.
32. Igoumenakis D, Glannakopoulos NN, Parara E, et al. Effect 
of causative tooth extraction on clinical and biological parameters 
of odontogenic infection: a prospective clinical trial. J Oral Maxil-
lofac Surg 2015; 73: 1254-1258. 
33. Johri A. Should teeth be extracted immediately in the  presence 
of acute infection? Oral Maxillofac Surg Clin North Am 2011; 23: 507.
34. Jepsen S, Berglund T, Zitzmann NU. Primary prevention of peri- 
implantitis: managing peri-implant mucositis. J Clin Periodontol 
2015; 42 Suppl 16: S152-7.
35. Kreutzer K, Storck K, Weitz J. Current evidence regarding pro-
phylactic antibiotics in head and neck and maxillofacial surgery. 
Biomed Res Int 2014; 879437.
36. Kumari S, Mohanty S, Sharma P, et al. Is the routine practice of an-
tibiotic prescription and microbial culture and antibiotic sensi-
tivity testing justified in primary maxillofacial space infection 
patients? A prospective, randomized, comparative clinical study. 
J Craniomaxillofac Surg 2018; 46: 446-452.
37. Kuriyama T, Lewis MA, Williams DW. Infections of the oral and 
maxillofacial region. In: Andresson L, Kahnberg KE, Pogrel MA. 
Oral and maxillofacial surgery. Wiley-Blackwell, Oxford 2010: 
465-578.
38. Lee CT, Huang YW, Liang Z, Weltman R. Prevalences of  peri- 
implantitis and peri-implant mucositis: systematic review and 
meta-analysis. J Dent 2017; 62: 1-12. 
39. Lewis MA. Why we must reduce dental prescription of antibiotics: 
European Union Antibiotics Awareness Day. Br Dent J 2009; 205: 
537-538.
40. Lindeboom JAH, van den Akker HP. A prospective placebo-con-
trolled double-blind trial of  antibiotic prophylaxis in intraoral 
bone grafting procedures: a pilot study. Oral Surg Oral Med Oral 
Pathol Oral Radiol Endod 2003; 96: 669-672.
41. Lindeboom JAH, Tuk JG, Kroon FK, van den Akker HP. A ran-
domized prospective controlled trial of antibiotic prophylaxis in 
intraoral bone grafting procedures: single-dose clindamycin ver-
sus 24-hour clindamycin prophylaxis. Mund Kiefer Gesichts Chir 
2005; 9: 384-388.
42. Lindeboom JAH, Franken JW, Valkenburg P, van den Akker HP. 
The  role of  preoperative antibiotic administration in periapical 
endodontic surgery. Int Endod J 2005; 38: 877-881.
43. Lindeboom JA, Frenken JW, Tuk JG, Kroon FH. A randomized 
prospective controlled trial of antibiotic prophylaxis in intraoral 
bone-grafting procedures: preoperative single dose penicillin ver-
sus preoperative single dose clindamycin. Int J Oral Maxillofac 
Surg 2006; 35: 433-436.
44. Lodi G, Figini L, Sardella A, et al. Antibiotics to prevent compli-
cations following tooth extractions. Cochrane Database Syst Rev 
2012; 11: CD003811. 
45. Löfmark S, Jernberg C, Jansson JK, Edlund C. Clindamycin-induced 
enrichment and long-term persistence of resistant Bacteroides spp. 
and resistance genes. J Antimicrob Chemother 2006; 58: 1160-1167.
46. Malmgren B, Andreasen JO, Flores MT, et al. International As-
sociation of Dental Traumatology guidelines for the management 
of  traumatic dental injuries: Injuries in the  primary dentition. 
Dent Traumatol 2012; 28: 174-82. 
47. Martin MV, Kanatas AN, Hardy P. Antibiotic prophylaxis and 
third molar surgery. Br Dent J 2005; 198: 327-330.
48. Martins JR, Hagas OL Jr, Velasquez BD, et al. The use of antibi-
otics in odontogenic unfections: what is the best choice? A sys-
tematic review. J Oral Maxillofac Surg 2017; 75: 2606.e1-2606.e11.
49. Mauceri R, Campisi G, Matranga D, et al. The role of antibiotic 
prophylaxis in reducing bacterial contamination of  autologous 
bone graft collected from implant site. Biomed Res Int 2017; 
2175019.
50. Miller C. Decisions and antibiotic use: more questions and some 
answers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 
2010; 110: 1-3. 
51. Mohan RR, Doraswamy DC, Hussain AM, et al. Evaluation 
of the role of antibiotics in preventing postoperative complication 
after routine periodontal surgery: a  comparative clinical study. 
J Indian Soc Periodontol 2014; 18: 205-212. 
52. Mombelli A, Samaranyake LP. Topical and systemic antibiotics in 
the management of periodontal diseases. Int Dent J 2004; 54: 3-14. 
53. Montefusco V, Gay F, Spina F, et al. Antibiotic prophylaxis before 
dental procedures may reduce the  incidence of  osteonecrosis 
of the jaw in patients with multiple myeloma treated with bisphos-
phonates. Leuk Lymph 2008; 49: 2156-2162.
54. Oberoi SS, Dhingra C, Sharma G, Sardana D. Antibiotics in dental 
practice: how justify are we. Int Dent J 2015; 65: 4-10.
55. Olczak-Kowalczyk D, Karolak-Żak D, Tymińska D, Krasuska- 
Sławińska D. Antybiotyki w stomatologii dziecięcej. Nowa Stom 
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